We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Mechanism of cisplatin resistance in gastric cancer and associated microRNAs

    Gastric cancer (GC) is a common malignant tumor with high morbidity and mortality rates that seriously affects human health worldwide. Although...

    Changqing Liu, Shan Li, Yunlian Tang in Cancer Chemotherapy and Pharmacology
    Article 03 August 2023
  2. Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir

    The Food and Drug Administration (FDA) has licensed many antiretroviral medications to treat human immunodeficiency virus type 1 (HIV-1), however,...

    Mohsen Heidary, Saeedeh Shariati, ... Vahab Hassan Kaviar in BMC Infectious Diseases
    Article Open access 23 February 2024
  3. Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA

    Breast cancer (BC) ranks first among female malignant tumors and involves hormonal changes and genetic as well as environmental risk factors. In...

    Simin Ye, Shiyu Chen, ... **aoyong Lei in Discover Oncology
    Article Open access 01 May 2024
  4. Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation

    Macrophages constitute a major part of tumor microenvironment, and most of existing data demonstrate their ruling role in the development of...

    Alina D. Nikotina, Snezhana A. Vladimirova, ... Irina V. Guzhova in Cancer Immunology, Immunotherapy
    Article Open access 27 January 2024
  5. Holistic anti-tumor resistance mechanism of YBX1 and its potential as a chemoresistance target in pancreatic ductal adenocarcinoma

    The overall survival rate of pancreatic ductal adenocarcinoma (PDAC) is the worst among all cancers, which is mainly due to the fact that most...

    Zheng Li, Haidi Chen, ... **anjun Yu in Holistic Integrative Oncology
    Article Open access 06 June 2023
  6. ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma

    Patients with metastatic acral lentiginous melanoma (ALM) suffer worse outcomes relative to patients with other forms of cutaneous melanoma (CM), and...

    Kasturee Jagirdar, Marie E. Portuallo, ... Vito W. Rebecca in Oncogene
    Article Open access 08 December 2023
  7. Molecular mechanism of XB130 adaptor protein mediates trastuzumab resistance in gastric cancer

    Background

    Recent studies have shown that the activation of PI3K/AKT signaling pathway is an essential molecular mechanism participating in...

    Shengnan Yang, Binbin Wang, ... Qiang Zuo in Clinical and Translational Oncology
    Article 25 October 2022
  8. Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

    Despite the approval of several drugs for AML, cytarabine is still widely used as a therapeutic approach. However, 85% of patients show resistance...

    María Luz Morales, Roberto García-Vicente, ... María Linares in Leukemia
    Article Open access 08 July 2023
  9. Adipose-derived extracellular vesicles – a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome

    Obesity is the best described risk factor for the development of non-alcoholic fatty liver disease (NAFLD)/metabolic dysfunction associated steatotic...

    Dušan Mladenović, Milena Vesković, ... Djuro Macut in Endocrine
    Article 29 January 2024
  10. Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

    Internal tandem duplications (ITD) in the receptor tyrosine kinase FLT3 occur in 25 % of acute myeloid leukemia (AML) patients, drive leukemia...

    Sebastian E. Koschade, Kevin Klann, ... Christian H. Brandts in Leukemia
    Article Open access 23 August 2022
  11. Molecular mechanism of MLCK1 inducing 5-Fu resistance in colorectal cancer cells through activation of TNFR2/NF-κB pathway

    Background and aims

    Chemotherapy resistance in colorectal cancer have been faced with significant challenges in recent years. Particular interest is...

    Huifen Tang, Hui Zhou, ... Ning Li in Discover Oncology
    Article Open access 12 May 2024
  12. Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report

    Small cell transformation was one mechanism by which EGFR -mutation NSCLC acquired resistance after tyrosine kinase inhibitors (TKIs) treatment. A few...

    Yan Peng, Zhu Zheng, ... Sun Meili in BMC Pulmonary Medicine
    Article Open access 06 December 2023
  13. Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism

    Purpose

    Although lorlatinib, the third generation of echinoderm microtubule protein 4-anaplastic lymphoma kinase (EML4-ALK) tyrosine kinase inhibitor...

    Bo **e, Ying Qiu, ... Weimin Zhang in Clinical and Translational Oncology
    Article 19 July 2022
  14. Butyrate driven raft disruption trots off enteric pathogen invasion: possible mechanism of colonization resistance

    The gut microbiome derived short chain fatty acids perform multitude of functions to maintain gut homeostasis. Here we studied how butyrate stymie...

    Oishika Das, Aaheli Masid, ... Moumita Bhaumik in Gut Pathogens
    Article Open access 21 April 2023
  15. The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters

    Background

    The drug resistance of tumor stem cells is an obstacle in gastric cancer (GC) treatment and the high expression of ABC transporters is a...

    Wenjie Huang, Fang Wen, ... Peng Shu in Chinese Medicine
    Article Open access 09 August 2022
  16. Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1

    The androgen receptor (AR) is a central driver of aggressive prostate cancer. After initial treatment with androgen receptor signaling inhibitors...

    James E. Melnyk, Veronica Steri, ... Kevan M. Shokat in Oncogene
    Article Open access 27 January 2022
  17. Mechanism of insulin resistance in obesity: a role of ATP

    Obesity increases the risk of type 2 diabetes through the induction of insulin resistance. The mechanism of insulin resistance has been extensively...

    Jian** Ye in Frontiers of Medicine
    Article Open access 28 May 2021
  18. Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition

    Acquired resistance to molecular targeted therapy is a significant challenge of the precision medicine era. The ability to understand these...

    Niamh Coleman, Vivek Subbiah, ... Funda Meric-Bernstam in npj Precision Oncology
    Article Open access 01 December 2021
  19. A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent chordoma patient with molecular alterations treated with Palbociclib

    Purpose

    There is no approved targeted therapy for chordoma at present. Although several preclinical studies have implied the potential applicability...

    Nanzhe Zhong, Dong Yu, ... Jianru **ao in Journal of Cancer Research and Clinical Oncology
    Article Open access 19 February 2024
  20. O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination

    The molecular mechanism of glioblastoma (GBM) radiation resistance remains poorly understood. The aim of this study was to elucidate the potential...

    Lei Xu, Yangfan Ye, ... **g Ji in Oncogene
    Article 10 November 2023
Did you find what you were looking for? Share feedback.